Back
Avalo Therapeutics Quote, Financials, Valuation and Earnings
DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon
Discover our top DeFi pick for potentially massive gains now (before it's too late).
Sell
39
AVTX
Avalo Therapeutics
Last Price:
15.37
Seasonality Move:
-13.32%
7 Day Trial
ALL ACCESS PASS
$
7
MarketBeat Alert: Strong sell signal just issued for these 20 stocks
Go here now to get free instant access to all 20 stocks to sell.Avalo Therapeutics Price Quote
$15.37
-0.57 (2.6%)
(Updated: April 27, 2024 at 5:54 AM ET)
Avalo Therapeutics Key Stats
Sell
39
Avalo Therapeutics (AVTX)
is a Sell
Day range:
$14.69 - $16.23
52-week range:
$3.95 - $1,130.40
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.28
P/B ratio:
2.26%
Volume:
78.1K
Avg. volume:
1.4M
1-year change:
-97.8%
Market cap:
$16.5M
Revenue:
$1.9M
EPS:
$-382.19
How Much Does Avalo Therapeutics Make?
-
How Much Are Avalo Therapeutics's Sales Annually?
AVTX Revenues are $1.9M -
How Much Profit Does Avalo Therapeutics's Make A Year?
AVTX net income is -$31.5M
Is Avalo Therapeutics Growing As A Company?
-
What Is Avalo Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.36% -
What Is Avalo Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Avalo Therapeutics Stock Price Performance
-
Did Avalo Therapeutics Stock Go Up Last Month?
Avalo Therapeutics share price went up by 244.71% last month -
Did AVTX's Share Price Rise Over The Last Year?
AVTX share price fell by -97.8% over the past 1 year
What Is Avalo Therapeutics 52-Week High & Low?
-
What Is Avalo Therapeutics’s 52-Week High Share Price?
Avalo Therapeutics has traded as high as $1,130.40 over the past 52 weeks -
What Is Avalo Therapeutics’s 52-Week Low Share Price?
Avalo Therapeutics has traded as low as $3.95 over the past 52 weeks
Avalo Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Avalo Therapeutics?
-
How Much Debt Does Avalo Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Avalo Therapeutics Have?
Cash and short term investments quarterly total is $7.4M -
What Is Avalo Therapeutics’s Book Value Per Share?
Book value per share is 9.11
Is Avalo Therapeutics Cash Flow Positive?
-
What Is AVTX Cash Flow From Operations?
Cash flow from operations (TTM) is -$30.7M -
What Is Avalo Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $25M -
What Is Avalo Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$133K
Avalo Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
AVTX return on invested capital is -308.38% -
What Is Avalo Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -109.45% -
What Is AVTX Return On Equity?
ROE is a measure of profitability and is 0%
Avalo Therapeutics Earnings Date & Stock Price
-
What Is Avalo Therapeutics's Stock Price Today?
A single share of AVTX can be purchased today for 15.94 -
What Is Avalo Therapeutics’s Stock Symbol?
Avalo Therapeutics trades on the nasdaq under the ticker symbol: AVTX -
When Is Avalo Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Avalo Therapeutics is scheduled on May 3, 2024 -
When Is AVTX's next ex-dividend date?
Avalo Therapeutics's next ex-dividend date is April 28, 2024 -
How To Buy Avalo Therapeutics Stock?
You can buy Avalo Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Avalo Therapeutics Competitors
-
Who Are Avalo Therapeutics's Competitors?
Below is a list of companies who compete with Avalo Therapeutics or are related in some way:
Avalo Therapeutics Dividend Yield
Data Unavailable
Avalo Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | -36.27% | 90.33% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 35.00 |
| Upside from Last Price: | 119.57% |